Concert Pharmaceuticals CFO Ryan Daws to Leave in June

Concert Pharmaceuticals said early Tuesday CFO Ryan Daws will be leaving the company in early June. Daws, who has served as CFO since January 2014, will continue to work with the company as a consultant, including through the closing of a pending asset-purchase agreement with Vertex Pharmaceuticals (VRTX). The search for a new CFO has begun.

Daws will be joining Baird as a managing director in the firm’s life sciences and biotechnology group, the company said in a statement.

Related posts

Leave a Comment